Učitavanje...
rt-PA plus Eptifibatide versus rt-PA Alone in Acute Ischemic Stroke: A Propensity Score Matched Post Hoc Analysis
BACKGROUND AND PURPOSE: The CLEAR-ER trial demonstrated safety of rt-PA plus eptifibatide in acute ischemic stroke (AIS). CLEAR-ER randomized AIS patients (5:1) to 0.6mg/kg rt-PA plus eptifibatide versus standard rt-PA (0.9mg/kg). IMS III randomized AIS patients to rt-PA plus endovascular therapy ve...
Spremljeno u:
| Izdano u: | Stroke |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4308493/ https://ncbi.nlm.nih.gov/pubmed/25523054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.114.006743 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|